Benson J Ouma1, Paul Bangirana2, John M Ssenkusu3, Dibyadyuti Datta4, Robert O Opoka5, Richard Idro5,6, Kevin C Kain7, Chandy C John4, Andrea L Conroy8. 1. Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda. 2. Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda. 3. Department of Epidemiology and Biostatistics, College of Health Sciences, Makerere University, Kampala, Uganda. 4. Ryan White Center for Pediatric Infectious Disease and Global Health, Indiana University School of Medicine, Indianapolis, IN, USA. 5. Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. 6. Centre of Tropical Medicine and Global Health, University of Oxford, Oxford, UK. 7. Department of Medicine, University of Toronto and University Health Network, Toronto, Canada. 8. Ryan White Center for Pediatric Infectious Disease and Global Health, Indiana University School of Medicine, Indianapolis, IN, USA. conroya@iu.edu.
Abstract
BACKGROUND: Elevated angiopoietin-2 (Angpt-2) concentrations are associated with worse overall neurocognitive function in severe malaria survivors, but the specific domains affected have not been elucidated. METHODS: Ugandan children with severe malaria underwent neurocognitive evaluation a week after hospital discharge and at 6, 12 and 24 months follow-up. The relationship between Angpt-2 concentrations and age-adjusted, cognitive sub-scale z-scores over time were evaluated using linear mixed effects models, adjusting for disease severity (coma, acute kidney injury, number of seizures in hospital) and sociodemographic factors (age, gender, height-for-age z-score, socio-economic status, enrichment in the home environment, parental education, and any preschool education of the child). The Mullen Scales of Early Learning was used in children < 5 years and the Kaufman Assessment Battery for Children 2nd edition was used in children ≥ 5 years of age. Angpt-2 levels were measured on admission plasma samples by enzyme-linked immunosorbent assay. Adjustment for multiple comparisons was conducted using the Benjamini-Hochberg Procedure of False Discovery Rate. RESULTS: Increased admission Angpt-2 concentration was associated with worse outcomes in all domains (fine and gross motor, visual reception, receptive and expressive language) in children < 5 years of age at the time of severe malaria episode, and worse simultaneous processing and learning in children < 5 years of age at the time of severe malaria who were tested when ≥ 5 years of age. No association was seen between Angpt-2 levels and cognitive outcomes in children ≥ 5 years at the time of severe malaria episode, but numbers of children and testing time points were lower for children ≥ 5 years at the time of severe malaria episode. CONCLUSION: Elevated Angpt-2 concentration in children with severe malaria is associated with worse outcomes in multiple neurocognitive domains. The relationship between Angpt-2 and worse cognition is evident in children < 5 years of age at the time of severe malaria presentation and in selected domains in older years.
BACKGROUND: Elevated angiopoietin-2 (Angpt-2) concentrations are associated with worse overall neurocognitive function in severe malaria survivors, but the specific domains affected have not been elucidated. METHODS: Ugandan children with severe malaria underwent neurocognitive evaluation a week after hospital discharge and at 6, 12 and 24 months follow-up. The relationship between Angpt-2 concentrations and age-adjusted, cognitive sub-scale z-scores over time were evaluated using linear mixed effects models, adjusting for disease severity (coma, acute kidney injury, number of seizures in hospital) and sociodemographic factors (age, gender, height-for-age z-score, socio-economic status, enrichment in the home environment, parental education, and any preschool education of the child). The Mullen Scales of Early Learning was used in children < 5 years and the Kaufman Assessment Battery for Children 2nd edition was used in children ≥ 5 years of age. Angpt-2 levels were measured on admission plasma samples by enzyme-linked immunosorbent assay. Adjustment for multiple comparisons was conducted using the Benjamini-Hochberg Procedure of False Discovery Rate. RESULTS: Increased admission Angpt-2 concentration was associated with worse outcomes in all domains (fine and gross motor, visual reception, receptive and expressive language) in children < 5 years of age at the time of severe malaria episode, and worse simultaneous processing and learning in children < 5 years of age at the time of severe malaria who were tested when ≥ 5 years of age. No association was seen between Angpt-2 levels and cognitive outcomes in children ≥ 5 years at the time of severe malaria episode, but numbers of children and testing time points were lower for children ≥ 5 years at the time of severe malaria episode. CONCLUSION: Elevated Angpt-2 concentration in children with severe malaria is associated with worse outcomes in multiple neurocognitive domains. The relationship between Angpt-2 and worse cognition is evident in children < 5 years of age at the time of severe malaria presentation and in selected domains in older years.
Entities:
Keywords:
Angiopoietin-2; Children; Cognition; Severe malaria
Authors: E Shabani; B J Ouma; R Idro; P Bangirana; R O Opoka; G S Park; A L Conroy; C C John Journal: Parasite Immunol Date: 2017-05-28 Impact factor: 2.280
Authors: Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Kim Piera; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey Journal: Proc Natl Acad Sci U S A Date: 2008-10-28 Impact factor: 11.205
Authors: Chandy C John; Angela Panoskaltsis-Mortari; Robert O Opoka; Gregory S Park; Paul J Orchard; Anne M Jurek; Richard Idro; Justus Byarugaba; Michael J Boivin Journal: Am J Trop Med Hyg Date: 2008-02 Impact factor: 2.345
Authors: Andrea L Conroy; Happy Phiri; Michael Hawkes; Simon Glover; Mac Mallewa; Karl B Seydel; Terrie E Taylor; Malcolm E Molyneux; Kevin C Kain Journal: PLoS One Date: 2010-12-29 Impact factor: 3.240
Authors: Andrea L Conroy; Michael Hawkes; Chloe R McDonald; Hani Kim; Sarah J Higgins; Kevin R Barker; Sophie Namasopo; Robert O Opoka; Chandy C John; W Conrad Liles; Kevin C Kain Journal: Open Forum Infect Dis Date: 2016-06-20 Impact factor: 3.835
Authors: Dag Holmberg; Elisabeth Franzén-Röhl; Richard Idro; Robert O Opoka; Paul Bangirana; Carl M Sellgren; Ronny Wickström; Anna Färnert; Lilly Schwieler; Göran Engberg; Chandy C John Journal: Malar J Date: 2017-07-28 Impact factor: 2.979
Authors: Sanjib Mohanty; Laura A Benjamin; Megharay Majhi; Premanand Panda; Sam Kampondeni; Praveen K Sahu; Akshaya Mohanty; Kishore C Mahanta; Rajyabardhan Pattnaik; Rashmi R Mohanty; Sonia Joshi; Anita Mohanty; Ian W Turnbull; Arjen M Dondorp; Terrie E Taylor; Samuel C Wassmer Journal: mSphere Date: 2017-06-07 Impact factor: 4.389
Authors: Andrea L Conroy; Robert O Opoka; Paul Bangirana; Richard Idro; John M Ssenkusu; Dibyadyuti Datta; James S Hodges; Catherine Morgan; Chandy C John Journal: BMC Med Date: 2019-05-21 Impact factor: 8.775
Authors: Michael T Hawkes; Aleksandra Leligdowicz; Anthony Batte; Geoffrey Situma; Kathleen Zhong; Sophie Namasopo; Robert O Opoka; Kevin C Kain; Andrea L Conroy Journal: Pathogens Date: 2022-04-03